Viewing Study NCT00463866



Ignite Creation Date: 2024-05-05 @ 5:29 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00463866
Status: COMPLETED
Last Update Posted: 2010-03-22
First Post: 2007-04-19

Brief Title: Local Phase 4 Pan-European SMART Study
Sponsor: AstraZeneca
Organization: AstraZeneca

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2010-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate the effect of two different maintenance doses of Symbicort Maintenance And Reliever Therapy SMART in adult asthmatic patients A 6 month treatment period
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
EUROSMART None None None
EudraCTNo 2006-006512-30 None None None